Alexion Pharmaceuticals, Inc. (ALXN)

rh109605 (< 20) Submitted: 2/14/07 2:00 PM : Start Price: $19.80 ALXN Score: 111.38

I believe that this company's new cancer drug will draw in many investors over the next few months and the drug itself, which is in FDA review, looks like a definite winner. I suspect this stock to hit $65 , maybe as high as $80 by Q4 07.

Report this Post Replies: 3 | Reply | Permalink

abetens2 (98.56) Submitted: 4/29/08 8:38 AM : Start Price: $35.03 ALXN Score: -33.55

Paroxysmal Nocturnal Hemoglobinuria -- extremely rare condition. Can Alexion justify an extremely high price for because of the rarity of the disease? Probably not. Notice that they are recording sales but not receiving cash. Their accounts recei...

Report this Post Replies: 0 | Reply | Permalink

zzlangerhans (99.34) Submitted: 12/29/08 11:10 PM : Start Price: $34.26 ALXN Score: -2.13

I came home drunk one night last year and got in a big fight with Alexion. I called her a lot of bad names and said she'd never amount to anything and stormed out of our trailer. Well, she's done pretty well for herself since then, got a job and a br...

Report this Post Replies: 0 | Reply | Permalink

irishmanbob (< 20) Submitted: 11/05/07 3:15 PM : Start Price: $37.94 ALXN Score: -30.98

One might wonder why the run-up in price of a company whose claim to fame is just one orphan drug for a rare disease abbreviated PNH? I believe it's because of the future promise of this drug against diseases for which there has not been much success...

Report this Post Replies: 0 | Reply | Permalink

SapphireSeas (77.20) Submitted: 10/04/07 1:42 PM : Start Price: $34.35 ALXN Score: 41.59

Reuters, 10/4/07:

In a departure from the current status quo, Presidential front runner Senator Hillary Clinton would support stem cell funding and research.

That would be a boon for research efforts and for companies such...

Report this Post Replies: 0 | Reply | Permalink

star60629 (< 20) Submitted: 3/21/07 6:04 PM : Start Price: $19.67 ALXN Score: -111.52

Watch this thing go down.Muaahhh.Small rev,many shares,big talk=down

Report this Post Replies: 0 | Reply | Permalink

Rep07 (98.61) Submitted: 11/07/08 3:50 PM : Start Price: $40.73 ALXN Score: 12.39

I hate stocks with big expectations and big PEs. Yes ALXN has a successful drug, but still way way ahead of itself in the stock price. Could legitimately be cut in half from here. All of these "tech growth spec" stocks should be avoided across the...

Report this Post Replies: 0 | Reply | Permalink

MoneyDocSchloss (< 20) Submitted: 10/30/08 11:08 AM : Start Price: $39.90 ALXN Score: 8.28

overvalued.

Lee

Report this Post Replies: 0 | Reply | Permalink

olderwhiskey (55.02) Submitted: 10/25/08 8:53 AM : Start Price: $36.63 ALXN Score: -9.78

Earnings report: 29 cents per share, up from a loss of 28 cents a year ago.

Report this Post Replies: 0 | Reply | Permalink

MViscio1 (95.14) Submitted: 10/23/08 2:14 PM : Start Price: $37.34 ALXN Score: -12.27

PHARM STOCK

Report this Post Replies: 0 | Reply | Permalink